EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieMultizentrische StudieRandomisierte kontrollierte Studie

Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura

Marie Scully, Ana Antun, Spero R Cataland, Paul Coppo, Claire Dossier, Nathalie Biebuyck, Wolf-Achim Hassenpflug, Karim Kentouche, Paul Knöbl, Johanna A Kremer Hovinga, M Fernanda López-Fernández, Masanori Matsumoto und 12 weitere

New England Journal of Medicine · 02.05.2024 · 390 (17) · 1584-1596

DOI: 10.1056/nejmoa2314793 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 02.05.2024. Verfasst von Marie Scully und 23 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Haematology, University College London Hospitals, London (M.S.); the Department of Hematology and Medical Oncology, Emory Univ…. Hauptthemen laut MEDLINE: ADAMTS13 Protein, Purpura, Thrombotic Thrombocytopenic, Recombinant Proteins. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAMTS13 ProteinPurpura, Thrombotic ThrombocytopenicRecombinant ProteinsAdolescentAdultChildFemaleHumansMaleMiddle AgedYoung AdultCross-Over StudiesChild, Preschool

Substanzen

ADAMTS13 ProteinADAMTS13 protein, humanRecombinant Proteins

Autor:innen und Institutionen

  • From the Department of Haematology, University College London Hospitals, London (M.S.); the Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta (A.A.); the Department of Internal…

Förderung

  • Takeda Pharmaceutical Company

Zitieren

APA

Scully, M., Antun, A., Cataland, S. R., Coppo, P., Dossier, C., Biebuyck, N., Hassenpflug, W. A., Kentouche, K., Knöbl, P., Kremer Hovinga, J. A., López-Fernández, M. F., Matsumoto, M., Ortel, T. L., Windyga, J., Bhattacharya, I., Cronin, M., Li, H., Mellgård, B., Patel, M., …, & cTTP Phase 3 Study Investigators (2024). Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine, 390(17), 1584-1596. https://doi.org/10.1056/nejmoa2314793

Vancouver

Scully M, Antun A, Cataland SR, Coppo P, Dossier C, Biebuyck N, et al. Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine. 2024;390(17):1584-1596. doi:10.1056/nejmoa2314793

BibTeX
@article{Scully2024,
  author = {Scully, Marie and Antun, Ana and Cataland, Spero R and Coppo, Paul and Dossier, Claire and Biebuyck, Nathalie and Hassenpflug, Wolf-Achim and Kentouche, Karim and Knöbl, Paul and Kremer Hovinga, Johanna A and López-Fernández, M Fernanda and Matsumoto, Masanori and Ortel, Thomas L and Windyga, Jerzy and Bhattacharya, Indranil and Cronin, Michael and Li, Hong and Mellgård, Björn and Patel, Munjal and Patwari, Parth and Xiao, Shan and Zhang, Pinghai and Wang, Linda T and cTTP Phase 3 Study Investigators, cTTP Phase 3 Study Investigators},
  title = {Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {17},
  pages = {1584--1596},
  doi = {10.1056/nejmoa2314793}
}
Kostenlos starten →